ArticleArchives of Razi Institute2024

Recombinant fusion protein LipL41-OmpL1 as a Potential Candidate for a Cost-effective Vaccine against Leptospirosis.

M Eghbal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.